FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Isabell Sesterhenn

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Anatomy

Physiology

Gene Expression Regulation, Neoplastic

Genes & Molecular Sequences

Genes, Tumor Suppressor

Co-author Network

Publications

TOP 3
Philip Rosen; Isabell A Sesterhenn; Denise Young; Diana Böhm; Yongmei Chen; Jennifer Cullen; Albert Dobi; David G McLeod; Sven Perner; Gyorgy Petrovics; David Pfister; Shiv Srivastava
Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer.
C A Derosa; Albert Dobi; Bungo Furusato; David G McLeod; Martin E Nau; Yidong Chen; Lakshmi Ravindranath; Isabell A Sesterhenn; Syed Shaheduzzaman; M Siefert; Vasantha Srikantan; Shiv Srivastava; Maryanne Vahey; Z Wang; T Werner; D Young; M Seifert; Gyorgy Petrovics
Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression.
Philip Rosen; Isabell A Sesterhenn; Shiv Srivastava; Stephen A Brassell; David G McLeod; Albert Dobi
Clinical potential of the ERG oncoprotein in prostate cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Isabell Sesterhenn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Philip Rosen; Isabell A Sesterhenn; Denise Young; Diana Böhm; Yongmei Chen; Jennifer Cullen; Albert Dobi; David G McLeod; Sven Perner; Gyorgy Petrovics; David Pfister; Shiv Srivastava
Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer.
Urology 2012;80(4):749-53.
2012: C A Derosa; Albert Dobi; Bungo Furusato; David G McLeod; Martin E Nau; Yidong Chen; Lakshmi Ravindranath; Isabell A Sesterhenn; Syed Shaheduzzaman; M Siefert; Vasantha Srikantan; Shiv Srivastava; Maryanne Vahey; Z Wang; T Werner; D Young; M Seifert; Gyorgy Petrovics
Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression.
Prostate cancer and prostatic diseases 2012;15(2):150-6.
2012: Philip Rosen; Isabell A Sesterhenn; Shiv Srivastava; Stephen A Brassell; David G McLeod; Albert Dobi
Clinical potential of the ERG oncoprotein in prostate cancer.
Nature reviews. Urology 2012;9(3):131-7.
2012: Daniel J Heidenberg; Joel H Barton; Michael Grinkemeyer; Denise Young; Isabell A Sesterhenn
N-cadherin Expression in Testicular Germ Cell and Gonadal Stromal Tumors.
Journal of Cancer 2012;3():381-9.
2011: Ahmed A Mohamed; Shyh-Han Tan; Chen Sun; Syed Shaheduzzaman; Ying Hu; Gyorgy Petrovics; Yongmei Chen; Isabell A Sesterhenn; Hua Li; Taduru Sreenath; David G McLeod; Albert Dobi; Shiv Srivastava
ERG oncogene modulates prostaglandin signaling in prostate cancer cells.
Cancer biology & therapy 2011;11(4):410-7.
2010: D Hawksworth; Lakshmi Ravindranath; Yidong Chen; Bungo Furusato; Isabell A Sesterhenn; David G McLeod; Shiv Srivastava; Gyorgy Petrovics
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence.
Prostate cancer and prostatic diseases 2010;13(4):311-5.
2010: Amina Ali; Bungo Furusato; Paul O P Ts'o; Zhao-Ping Lum; Sally Elsamanoudi; Ahmed Mohamed; Shiv Srivastava; Judd W Moul; Stephen A Brassell; Isabell A Sesterhenn; David G McLeod
Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumors.
Pathology international 2010;60(10):667-72.
2010: Bungo Furusato; Shyh-Han Tan; D Young; Albert Dobi; Chen Sun; A A Mohamed; R Thangapazham; Yidong Chen; G McMaster; T Sreenath; Gyorgy Petrovics; David G McLeod; Shiv Srivastava; Isabell A Sesterhenn
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification.
Prostate cancer and prostatic diseases 2010;13(3):228-37.
2010: Emiko Furusato; J Douglas Cameron; Roger W Newsom; Takashi Fujishiro; Takayoshi Kojima; Charles S Specht; John F Fetsch; Bungo Furusato; Isabell A Sesterhenn; Elisabeth J Rushing
Ocular perivascular epithelioid cell tumor: report of 2 cases with distinct clinical presentations.
Human pathology 2010;41(5):768-72.
2010: Bungo Furusato; Toshiyuki Tsunoda; Syed Shaheduzzaman; Martin E Nau; Maryanne Vahey; Gyorgy Petrovics; David G McLeod; Seiji Naito; Senji Shirasawa; Shiv Srivastava; Isabell A Sesterhenn
Osteoblast-specific factor 2 expression in prostate cancer-associated stroma: identification through microarray technology.
Urology 2010;75(4):768-72.
2010: Kevin R Rice; Yongmei Chen; Amina Ali; Eric J Whitman; Amy Blase; Mona Ibrahim; Sally Elsamanoudi; Stephen Brassell; Bungo Furusato; Norbert Stingle; Isabell A Sesterhenn; Gyorgy Petrovics; Siobhan Miick; Harry Rittenhouse; Jack Groskopf; David G McLeod; Shiv Srivastava
Evaluation of the ETS-related gene mRNA in urine for the detection of prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(5):1572-6.
2010: K Mwamukonda; Y Chen; Lakshmi Ravindranath; Bungo Furusato; Y Hu; J Sterbis; D Osborn; Inger L Rosner; Isabell A Sesterhenn; David G McLeod; Shiv Srivastava; Gyorgy Petrovics
Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status.
Prostate cancer and prostatic diseases 2010;13(1):47-51.
2010: Motonobu Saito; Kensuke Kumamoto; Ana I Robles; Izumi Horikawa; Bungo Furusato; Shu Okamura; Akiteru Goto; Taro Yamashita; Makoto Nagashima; Tin-Lap Lee; Vanessa J Baxendale; Owen M Rennert; Seiichi Takenoshita; Jun Yokota; Isabell A Sesterhenn; Glenwood E Trivers; S Perwez Hussain; Curtis C Harris
Targeted disruption of Ing2 results in defective spermatogenesis and development of soft-tissue sarcomas.
PloS one 2010;5(11):e15541.
2010: Ahmed A Mohamed; Shyh-Han Tan; Natallia Mikhalkevich; Sathibalan Ponniah; Valeri Vasioukhin; Charles J Bieberich; Isabell A Sesterhenn; Albert Dobi; Shiv Srivastava; Taduru L Sreenath
Ets family protein, erg expression in developing and adult mouse tissues by a highly specific monoclonal antibody.
Journal of Cancer 2010;1():197-208.
2009: Kevin R Rice; Bungo Furusato; Yongmei Chen; David G McLeod; Isabell A Sesterhenn; Stephen A Brassell
Clinicopathological behavior of single focus prostate adenocarcinoma.
The Journal of urology 2009;182(6):2689-94.
2009: Toshiyuki Tsunoda; Bungo Furusato; Yasuo Takashima; Suma Ravulapalli; Albert Dobi; sudhir srivastava; David G McLeod; Isabell A Sesterhenn; David K Ornstein; Senji Shirasawa
The increased expression of periostin during early stages of prostate cancer and advanced stages of cancer stroma.
The Prostate 2009;69(13):1398-403.
2009: Steven J Weissbart; Fernando J Bianco; Marines Sotelo; Mohamed A Atalla; Isabell A Sesterhenn; Thomas W Jarrett
Glassy cell carcinoma of the urethra.
Urology 2009;73(1):60.
2008: Eric J Whitman; Jack Groskopf; Amina Ali; Yongmei Chen; Amy Blase; Bungo Furusato; Gyorgy Petrovics; Mona Ibrahim; Sally Elsamanoudi; Jennifer Cullen; Isabell A Sesterhenn; Stephen Brassell; Harry Rittenhouse; Shiv Srivastava; David G McLeod
PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.
The Journal of urology 2008;180(5):1975-8; discussion 1978-9.
2008: Bungo Furusato; Inger L Rosner; D Osborn; A Ali; sudhir srivastava; C J Davis; Isabell A Sesterhenn; David G McLeod
Do patients with low volume prostate cancer have prostate specific antigen recurrence following radical prostatectomy?
Journal of clinical pathology 2008;61(9):1038-40.
2008: Ying Hu; Albert Dobi; Taduru Sreenath; Christopher Cook; Atekelt Y Tadase; Lakshmi Ravindranath; Jennifer Cullen; Bungo Furusato; Yongmei Chen; Rajesh L Thangapazham; Ahmed Mohamed; Chen Sun; Isabell A Sesterhenn; David G McLeod; Gyorgy Petrovics; Shiv Srivastava
Delineation of TMPRSS2-ERG splice variants in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(15):4719-25.
2008: Joseph R Sterbis; Chunling Gao; Bungo Furusato; Yongmei Chen; Syed Shaheduzzaman; Lakshmi Ravindranath; David J Osborn; Inger L Rosner; Albert Dobi; David G McLeod; Isabell A Sesterhenn; Shiv Srivastava; Jennifer Cullen; Gyorgy Petrovics
Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(3):758-63.
2008: Bungo Furusato; Chun-Ling Gao; Lakshmi Ravindranath; Yongmei Chen; Jennifer Cullen; David G McLeod; Albert Dobi; Shiv Srivastava; Gyorgy Petrovics; Isabell A Sesterhenn
Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(2):67-75.
2008: Sandi Kwee; Gregory P Thibault; Richard S Stack; Marc N Coel; Bungo Furusato; Isabell A Sesterhenn
Use of step-section histopathology to evaluate 18F-fluorocholine PET sextant localization of prostate cancer.
Molecular imaging 2008;7(1):12-20.
2008: L W Chu; Yong Zhu; K Yu; Tongzhang Zheng; H Yu; Y Zhang; Isabell A Sesterhenn; Anand P Chokkalingam; K N Danforth; M-C Shen; Frank Z Stanczyk; Yu-Tang Gao; Ann W Hsing
Variants in circadian genes and prostate cancer risk: a population-based study in China.
Prostate cancer and prostatic diseases 2008;11(4):342-8.
2008: Bungo Furusato; S Shaheduzzaman; G Petrovics; A Dobi; M Seifert; L Ravindranath; M E Nau; T Werner; Maryanne Vahey; David G McLeod; Shiv Srivastava; Isabell A Sesterhenn
Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens.
Prostate cancer and prostatic diseases 2008;11(2):194-7.
2007: Inger L Rosner; Lakshmi Ravindranath; Bungo Furusato; Yongmei Chen; Chunling Gao; Jennifer Cullen; Isabell A Sesterhenn; David G McLeod; Shiv Srivastava; Gyorgy Petrovics
Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.
Urology 2007;70(6):1225-9.
2007: Ann W Hsing; Lori Sakoda; Jinbo Chen; Anand P Chokkalingam; Isabell A Sesterhenn; Yu-Tang Gao; Jianfeng Xu; S Lilly Zheng
MSR1 variants and the risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.
Carcinogenesis 2007;28(12):2530-6.
2007: Konstantin Shilo; Tatiana Dracheva; Haresh Mani; Junya Fukuoka; Isabell A Sesterhenn; Wei-Sing Chu; Joanna H Shih; Jin Jen; William D Travis; Teri J Franks
Alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis.
Archives of pathology & laboratory medicine 2007;131(10):1555-60.
2007: Syed Shaheduzzaman; Anu Vishwanath; Bungo Furusato; Jennifer Cullen; Yidong Chen; Lionel Bañez; Martin E Nau; Lakshmi Ravindranath; Kee-Hong Kim; Ahmed Mohammed; Yidong Chen; Mathias Ehrich; Vasantha Srikantan; Isabell A Sesterhenn; David McLeod; Maryanne Vahey; Gyorgy Petrovics; Albert Dobi; Shiv Srivastava
Silencing of Lactotransferrin expression by methylation in prostate cancer progression.
Cancer biology & therapy 2007;6(7):1088-95.
2007: Jun Miki; Bungo Furusato; Hongzhen Li; Yongpeng Gu; Hiroyuki Takahashi; Shin Egawa; Isabell A Sesterhenn; David G McLeod; Shiv Srivastava; Johng S Rhim
Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
Cancer research 2007;67(7):3153-61.
2007: Bungo Furusato; Stacey Koff; David G McLeod; Isabell A Sesterhenn
Sarcoidosis of the prostate.
Journal of clinical pathology 2007;60(3):325-6.
2007: Katherine A McGlynn; Lori Sakoda; Mark V Rubertone; Isabell A Sesterhenn; Christopher Lyu; Barry I Graubard; Ralph L Erickson
Body size, dairy consumption, puberty, and risk of testicular germ cell tumors.
American journal of epidemiology 2007;165(4):355-63.
2007: Mark P Purdue; Lori Sakoda; Barry I Graubard; Robert Welch; STEPHEN CHANOCK; Isabell A Sesterhenn; Mark V Rubertone; Ralph L Erickson; Katherine A McGlynn
A case-control investigation of immune function gene polymorphisms and risk of testicular germ cell tumors.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(1):77-83.
2006: Mei Sun; Vasantha Srikantan; Lanfeng Ma; Jia Li; Wei Zhang; Gyorgy Petrovics; Mazen Makarem; Jeffrey W Strovel; Stephen G Horrigan; Meena Augustus; Isabell A Sesterhenn; Judd W Moul; Settara C Chandrasekharappa; Zhiqiang Zou; Shiv Srivastava
Characterization of frequently deleted 6q locus in prostate cancer.
DNA and cell biology 2006;25(11):597-607.
2006: Charles J Davis; Joel H Barton; Isabell A Sesterhenn
Cystic angiomyolipoma of the kidney: a clinicopathologic description of 11 cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(5):669-74.
2006: Yongpeng Gu; Hongzhen Li; Jun Miki; Kee-Hong Kim; Bungo Furusato; Isabell A Sesterhenn; Wei-Sing Chu; David G McLeod; Shiv Srivastava; Charles M Ewing; William B Isaacs; Johng S Rhim
Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines.
Experimental cell research 2006;312(6):831-43.
2006: Jade J Wong-You-Cheong; Paula J Woodward; Maria A Manning; Isabell A Sesterhenn
From the Archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation.
Radiographics : a review publication of the Radiological Society of North America, Inc 2006;26(2):553-80.
2006: Linda L Xu; Chen Sun; Gyorgy Petrovics; Mazen Makarem; Bungo Furusato; Wei Zhang; Isabell A Sesterhenn; David G McLeod; Leon Sun; Judd W Moul; Shiv Srivastava
Quantitative expression profile of PSGR in prostate cancer.
Prostate cancer and prostatic diseases 2006;9(1):56-61.
2005: Ziya Kirkali; Theresa Y Chan; Murugesan Manoharan; Ferran Algaba; Christer Busch; Liang Cheng; Lambertus A L M Kiemeney; Martin Kriegmair; R Montironi; William M Murphy; Isabell A Sesterhenn; Masaaki Tachibana; Jeff Weider
Bladder cancer: epidemiology, staging and grading, and diagnosis.
Urology 2005;66(6 Suppl 1):4-34.
2005: Brian L Hood; Marlene M Darfler; Thomas G Guiel; Bungo Furusato; David A Lucas; Bradley R Ringeisen; Isabell A Sesterhenn; Thomas P Conrads; Timothy D Veenstra; David B Krizman
Proteomic analysis of formalin-fixed prostate cancer tissue.
Molecular & cellular proteomics : MCP 2005;4(11):1741-53.
2005: Wei-Sing Chu; Bungo Furusato; Kondi Wong; Isabell A Sesterhenn; Fathollah K Mostofi; Min Qi Wei; Zhenqing Zhu; Susan L Abbondanzo; Qi Liang
Ultrasound-accelerated formalin fixation of tissue improves morphology, antigen and mRNA preservation.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(6):850-63.
2005: Gyorgy Petrovics; Aijun Liu; Syed Shaheduzzaman; Bungo Furusato; Bungo Furasato; Chen Sun; Yidong Chen; Martin E Nau; Lakshmi Ravindranath; Yidong Chen; Albert Dobi; Vasantha Srikantan; Isabell A Sesterhenn; David G McLeod; Maryanne Vahey; Judd W Moul; Shiv Srivastava
Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.
Oncogene 2005;24(23):3847-52.
2005: William B Laskin; John F Fetsch; Charles J Davis; Isabell A Sesterhenn
Granular cell tumor of the penis: clinicopathologic evaluation of 9 cases.
Human pathology 2005;36(3):291-8.
2005: Y Bai; Y-T Gao; J Deng; Isabell A Sesterhenn; Joseph Fraumeni; A W Hsing
Risk of prostate cancer and family history of cancer: a population-based study in China.
Prostate cancer and prostatic diseases 2005;8(1):60-5.
2004: Isabell A Sesterhenn; Charles J Davis
Pathology of germ cell tumors of the testis.
Cancer control : journal of the Moffitt Cancer Center 2004;11(6):374-87.
2004: John F Fetsch; Isabell A Sesterhenn; Markku Miettinen; Charles J Davis
Epithelioid hemangioma of the penis: a clinicopathologic and immunohistochemical analysis of 19 cases, with special reference to exuberant examples often confused with epithelioid hemangioendothelioma and epithelioid angiosarcoma.
The American journal of surgical pathology 2004;28(4):523-33.
2004: John F Fetsch; Charles J Davis; James R Hallman; Luke S Chung; George P Lupton; Isabell A Sesterhenn
Lymphedematous fibroepithelial polyps of the glans penis and prepuce: a clinicopathologic study of 7 cases demonstrating a strong association with chronic condom catheter use.
Human pathology 2004;35(2):190-5.
2004: Gyorgy Petrovics; Wei Zhang; Mazen Makarem; Jesse P Street; Roger R Connelly; Leon Sun; Isabell A Sesterhenn; Vasantha Srikantan; Judd W Moul; Shiv Srivastava
Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients.
Oncogene 2004;23(2):605-11.
2004: John F Fetsch; Charles J Davis Jr; Markku Miettinen; Isabell A Sesterhenn
Leiomyosarcoma of the penis: a clinicopathologic study of 14 cases with review of the literature and discussion of the differential diagnosis.
The American journal of surgical pathology 2004;28(1):115-25.
2003: Linda L Xu; Yinghui Shi; Gyorgy Petrovics; Chen Sun; Mazen Makarem; Wei Zhang; Isabell A Sesterhenn; David G McLeod; Leon Sun; Judd W Moul; Shiv Srivastava
PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression.
Cancer research 2003;63(15):4299-304.
2003: Chun-Ling Gao; Sudhir K Rawal; Leon Sun; Amina Ali; Roger R Connelly; Lionel L Bañez; Isabell A Sesterhenn; David G McLeod; Judd W Moul; Shiv Srivastava
Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2545-50.
2003: Daejin Ko; Yongpeng Gu; Yutaka Yasunaga; Keiichiro Nakamura; Shiv Srivastava; Judd W Moul; Isabell A Sesterhenn; David G McLeod; Paul Arnstein; D O Taylor; Bharati Hukku; Johng S Rhim
A novel neoplastic primary tumor-derived human prostate epithelial cell line.
International journal of oncology 2003;22(6):1311-7.
2003: G L Griewe; RC Dean; Wei Zhang; D Young; Isabell A Sesterhenn; N Shanmugam; David G McLeod; Judd W Moul; Shiv Srivastava
p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
Prostate cancer and prostatic diseases 2003;6(4):281-5.
2003: Paula J Woodward; Cornelia M Schwab; Isabell A Sesterhenn
From the archives of the AFIP: extratesticular scrotal masses: radiologic-pathologic correlation.
Radiographics : a review publication of the Radiological Society of North America, Inc 2003;23(1):215-40.
2003: Axel S Merseburger; Markus A Kuczyk; Jürgen Serth; Carsten Bokemeyer; Denise Y Young; Leon Sun; Roger R Connelly; David G McLeod; Fathollah K Mostofi; Shiv K Srivastava; Arnulf Stenzl; Judd W Moul; Isabell A Sesterhenn
Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues.
Oncology reports 2003;10(1):223-8.
2002: Takehiko Segawa; Martin E Nau; Linda L Xu; Rao N Chilukuri; Mazen Makarem; Wei Zhang; Gyorgy Petrovics; Isabell A Sesterhenn; David G McLeod; Judd W Moul; Maryanne Vahey; Shiv Srivastava
Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells.
Oncogene 2002;21(57):8749-58.
2002: Leland D Davis; Wei Zhang; Axel S Merseburger; Denise Young; Linda Xu; Johng S Rhim; Judd W Moul; Shiv Srivastava; Isabell A Sesterhenn
p63 expression profile in normal and malignant prostate epithelial cells.
Anticancer research 2002;22(6C):3819-25.
2002: Mei Sun; Lanfeng Ma; Linda Xu; Jia Li; Wei Zhang; Gyorgy Petrovics; Mazen Makarem; Isabell A Sesterhenn; Mei Zhang; E Joan Blanchette-Mackie; Judd W Moul; Shiv Srivastava; Zhiqiang Zou
A human novel gene DERPC on 16q22.1 inhibits prostate tumor cell growth and its expression is decreased in prostate and renal tumors.
Molecular medicine (Cambridge, Mass.) 2002;8(10):655-63.
2002: Anand P Chokkalingam; Yu-Tang Gao; Jie Deng; Frank Z Stanczyk; Isabell A Sesterhenn; Fathollah K Mostofi; Joseph Fraumeni; Ann W Hsing
Insulin-like growth factors and risk of benign prostatic hyperplasia.
The Prostate 2002;52(2):98-105.
2002: Zhiqiang Zou; Wei Zhang; Denise Young; Martin G Gleave; Paul Rennie; Theresa Connell; Roger R Connelly; Judd W Moul; Shiv Srivastava; Isabell A Sesterhenn
Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1172-7.
2002: Ann W Hsing; Anand P Chokkalingam; Yu-Tang Gao; Guan Wu; Xin Wang; Jie Deng; Jiaorong Cheng; Isabell A Sesterhenn; Fathollah K Mostofi; Tzuying Chiang; Yuh-Ling Chen; Frank Z Stanczyk; Chawnshang Chang
Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(4):337-41.
2002: A Desai; H Wu; Leon Sun; Isabell A Sesterhenn; Fathollah K Mostofi; D McLeod; Christopher L Amling; Leo Kusuda; Raymond Lance; Judy Herring; J Foley; D Baldwin; Jay T Bishoff; Douglas W Soderdahl; Judd W Moul
Complete embedding and close step-sectioning of radical prostatectomy specimens both increase detection of extra-prostatic extension, and correlate with increased disease-free survival by stage of prostate cancer patients.
Prostate cancer and prostatic diseases 2002;5(3):212-8.
2002: M B Opell; J Zeng; JJ Bauer; Roger R Connelly; W Zhang; Isabell A Sesterhenn; Seong Mun; J W Moul; John H Lynch
Investigating the distribution of prostate cancer using three-dimensional computer simulation.
Prostate cancer and prostatic diseases 2002;5(3):204-8.
2002: Hala R Makhlouf; Kamal G Ishak; Raj Shekar; Isabell A Sesterhenn; Denise Y Young; Julie C Fanburg-Smith
Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study.
Archives of pathology & laboratory medicine 2002;126(1):49-55.
2001: Yutaka Yasunaga; Keiichiro Nakamura; Daejin Ko; Shiv Srivastava; Judd W Moul; Isabell A Sesterhenn; David G McLeod; Johng S Rhim
A novel human cancer culture model for the study of prostate cancer.
Oncogene 2001;20(55):8036-41.
2001: Edmond L Paquette; Roger R Connelly; Isabell A Sesterhenn; W Zhang; Leon Sun; Laurence R Paquette; R Greenspan; David G Mcleod; Judd W Moul
Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen era: implications for screening a high-risk group for prostate carcinoma.
Cancer 2001;92(10):2673-9.
2001: Ann W Hsing; Chu Chen; Anand P Chokkalingam; Yu-Tang Gao; D A Dightman; H T Nguyen; Jie Deng; J Cheng; Isabell A Sesterhenn; Fathollah K Mostofi; Frank Z Stanczyk; Juergen K V Reichardt
Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(10):1077-82.
2001: Anand P Chokkalingam; Katherine A McGlynn; Y T Gao; Michael Pollak; J Deng; Isabell A Sesterhenn; Fathollah K Mostofi; Joseph Fraumeni; Ann W Hsing
Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
Cancer research 2001;61(11):4333-6.
2001: Anand P Chokkalingam; Michael Pollak; Capri-Mara Fillmore; Yu-Tang Gao; Frank Z Stanczyk; Jie Deng; Isabell A Sesterhenn; Fathollah K Mostofi; Thomas R Fears; M Patricia Madigan; Regina G Ziegler; Joseph Fraumeni; Ann W Hsing
Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(5):421-7.
2001: James V Lacey; J Deng; Mustafa Dosemeci; Yu-Tang Gao; Fathollah K Mostofi; Isabell A Sesterhenn; T Xie; Ann W Hsing
Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, China.
International journal of epidemiology 2001;30(2):341-9.
2001: G L Griewe; R Dean; W Zhang; Isabell A Sesterhenn; sudhir srivastava; Judd W Moul
Laser-capture microdissection.
Methods in molecular medicine 2001;53():165-73.
2001: J Zeng; J Bauer; W Zhang; Isabell A Sesterhenn; Roger R Connelly; J Lynch; J Moul; Seong Mun
Prostate biopsy protocols: 3D visualization-based evaluation and clinical correlation.
Computer aided surgery : official journal of the International Society for Computer Aided Surgery 2001;6(1):14-21.
2000: Ann W Hsing; Jie Deng; Isabell A Sesterhenn; Fathollah K Mostofi; Frank Z Stanczyk; J Benichou; T Xie; Yu-Tang Gao
Body size and prostate cancer: a population-based case-control study in China.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(12):1335-41.
2000: Linda L Xu; B G Stackhouse; K Florence; Wei Zhang; N Shanmugam; Isabell A Sesterhenn; Zhiqiang Zou; Vasantha Srikantan; Meena Augustus; Viktor Roschke; K Carter; David G McLeod; Judd W Moul; D Soppett; Shiv Srivastava
PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer.
Cancer research 2000;60(23):6568-72.
2000: John F Fetsch; R W Brinsko; Charles J Davis; Fathollah K Mostofi; Isabell A Sesterhenn
A distinctive myointimal proliferation ('myointimoma') involving the corpus spongiosum of the glans penis: a clinicopathologic and immunohistochemical analysis of 10 cases.
The American journal of surgical pathology 2000;24(11):1524-30.
2000: Vasantha Srikantan; Zhiqiang Zou; Gyorgy Petrovics; L Xu; Meena Augustus; L Davis; Jeffrey Livezey; Theresa Connell; Isabell A Sesterhenn; K Yoshino; G S Buzard; Fathollah K Mostofi; David G McLeod; Judd W Moul; Shiv Srivastava
PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(22):12216-21.
2000: B Heidenreich; A Heidenreich; A Sesterhenn; sudhir srivastava; Judd W Moul; Isabell A Sesterhenn
Aneuploidy of chromosome 9 and the tumor suppressor genes p16(INK4) and p15(INK4B) detected by in situ hybridization in locally advanced prostate cancer.
European urology 2000;38(4):475-82.
2000: Ann W Hsing; Yu-Tang Gao; G Wu; X Wang; J Deng; Y L Chen; Isabell A Sesterhenn; Fathollah K Mostofi; J Benichou; Chawnshang Chang
Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Cancer research 2000;60(18):5111-6.
2000: Linda L Xu; N Shanmugam; Takehiko Segawa; Isabell A Sesterhenn; David G McLeod; Judd W Moul; Shiv Srivastava
A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate.
Genomics 2000;66(3):257-63.
2000: Linda L Xu; Vasantha Srikantan; Isabell A Sesterhenn; Meena Augustus; R Dean; Judd W Moul; KC Carter; Shiv Srivastava
Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
The Journal of urology 2000;163(3):972-9.
2000: J Zeng; JJ Bauer; X Yao; W Zhang; David G McLeod; Isabell A Sesterhenn; Roger R Connelly; J W Moul; Seong Mun
Investigating 3D tumor distribution for optimized diagnosis of prostate cancer.
Studies in health technology and informatics 2000;70():392-8.
2000: JJ Bauer; J Zeng; W Zhang; David G McLeod; Isabell A Sesterhenn; Roger R Connelly; Seong Mun; J W Moul
3-D computer visualization and interactive prostate biopsy simulation leads to an improved systematic technique for the detection of prostate cancer: clinical correlation.
Studies in health technology and informatics 2000;70():20-5.
2000: W Zhang; Isabell A Sesterhenn; Roger R Connelly; Fathollah K Mostofi; Judd W Moul
Inflammatory infiltrate (prostatitis) in whole mounted radical prostatectomy specimens from black and white patients is not an etiology for racial difference in prostate specific antigen.
The Journal of urology 2000;163(1):131-6.
1999: G B Stackhouse; Isabell A Sesterhenn; JJ Bauer; Fathollah K Mostofi; Roger R Connelly; S K Srivastava; Judd W Moul
p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy.
The Journal of urology 1999;162(6):2040-5.
1999: J H Barton; Charles J Davis; Isabell A Sesterhenn; Fathollah K Mostofi
Smooth muscle hyperplasia of the testicular adnexa clinically mimicking neoplasia: clinicopathologic study of sixteen cases.
The American journal of surgical pathology 1999;23(8):903-9.
1999: Judd W Moul; Roger R Connelly; RM Mooneyhan; W Zhang; Isabell A Sesterhenn; Fathollah K Mostofi; David G McLeod
Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients.
The Journal of urology 1999;162(2):394-7.
1999: Vasantha Srikantan; Isabell A Sesterhenn; L Davis; G R Hankins; F A Avallone; Jeffrey Livezey; Roger R Connelly; Fathollah K Mostofi; David G McLeod; Judd W Moul; Settara C Chandrasekharappa; Shiv Srivastava
Allelic loss on chromosome 6Q in primary prostate cancer.
International journal of cancer. Journal international du cancer 1999;84(3):331-5.
1999: JJ Bauer; J Zeng; J Weir; W Zhang; Isabell A Sesterhenn; Roger R Connelly; Seong Mun; Judd W Moul
Three-dimensional computer-simulated prostate models: lateral prostate biopsies increase the detection rate of prostate cancer.
Urology 1999;53(5):961-7.
1999: Axel Heidenreich; Isabell A Sesterhenn; Fathollah K Mostofi; J W Moul; Udo Engelmann
[Histopathologic and biological prognostic factors of clinical stage I non-seminomatous germ cell tumors. Implications for risk-adjusted therapy].
Der Urologe. Ausg. A 1999;38(2):168-78.
1999: J Zeng; J Bauer; W Zhang; Isabell A Sesterhenn; J Moul; Seong Mun
Prostate biopsy schemes: 3-D visualization-based evaluation.
Studies in health technology and informatics 1999;62():390-1.
1998: Douglas B Flieder; Michael N Koss; A Nicholson; Isabell A Sesterhenn; R E Petras; William D Travis
Solitary pulmonary papillomas in adults: a clinicopathologic and in situ hybridization study of 14 cases combined with 27 cases in the literature.
The American journal of surgical pathology 1998;22(11):1328-42.
1998: A Heidenreich; Isabell A Sesterhenn; Fathollah K Mostofi; Judd W Moul
Immunohistochemical expression of monoclonal antibody 43-9F in testicular germ cell tumours.
International journal of andrology 1998;21(5):283-8.
1998: Axel Heidenreich; Isabell A Sesterhenn; Fathollah K Mostofi; J W Moul
Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
Cancer 1998;83(5):1002-11.
1998: MC Bettencourt; JJ Bauer; Isabell A Sesterhenn; Roger R Connelly; Judd W Moul
CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy.
The Journal of urology 1998;160(2):459-65.
1998: JJ Bauer; Shiv Srivastava; Roger R Connelly; Isabell A Sesterhenn; DM Preston; David G McLeod; Judd W Moul
Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy.
Urology 1998;51(6):970-6.
1998: J W Moul; JJ Bauer; Isabell A Sesterhenn; G B Stackhouse; sudhir srivastava
Re: p53 protein and gene alterations in pathological stage C prostate carcinoma.
The Journal of urology 1998;159(5):1648-9.
1998: Jürgen F Linn; Isabell A Sesterhenn; Fathollah K Mostofi; Mark P Schoenberg
The molecular characteristics of bladder cancer in young patients.
The Journal of urology 1998;159(5):1493-6.
1998: Axel Heidenreich; N S Schenkman; Isabell A Sesterhenn; K F Mostofi; J W Moul; sudhir srivastava; Udo Engelmann
Immunohistochemical and mutational analysis of the p53 tumour suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumours.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1998;106(1):90-9; discussion 99-100.
1998: Judd W Moul; JJ Bauer; Shiv Srivastava; E Colon; C K Ho; Isabell A Sesterhenn; David G McLeod
Perineal seeding of prostate cancer as the only evidence of clinical recurrence 14 years after needle biopsy and radical prostatectomy: molecular correlation.
Urology 1998;51(1):158-60.
1997: Axel Heidenreich; S Neubauer; Fathollah K Mostofi; Isabell A Sesterhenn; J W Moul; Udo Engelmann
[Clinical stage I mature teratoma of the testis--retroperitoneal lymphadenectomy or surveillance?].
Der Urologe. Ausg. A 1997;36(5):440-4.
1997: A Heidenreich; N S Schenkmann; Isabell A Sesterhenn; Fathollah K Mostofi; W F McCarthy; B Heidenreich; Judd W Moul
Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors.
The Journal of urology 1997;158(2):620-5.
1997: T H Douglas; T O Morgan; David G McLeod; Judd W Moul; GP Murphy; RJ Barren; Isabell A Sesterhenn; Fathollah K Mostofi
Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients.
Cancer 1997;80(1):107-14.
1997: T H Douglas; David G McLeod; Fathollah K Mostofi; RM Mooneyhan; Roger R Connelly; Judd W Moul; Isabell A Sesterhenn
Prostate-specific antigen-detected prostate cancer (stage T1c): an analysis of whole-mount prostatectomy specimens.
The Prostate 1997;32(1):59-64.
1997: K Asgari; Isabell A Sesterhenn; David G McLeod; K Cowan; Judd W Moul; Prem Seth; Shiv Srivastava
Inhibition of the growth of pre-established subcutaneous tumor nodules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector.
International journal of cancer. Journal international du cancer 1997;71(3):377-82.
1997: P B Gaudin; Isabell A Sesterhenn; K J Wojno; Fathollah K Mostofi; Jonathan I Epstein
Incidence and clinical significance of high-grade prostatic intraepithelial neoplasia in TURP specimens.
Urology 1997;49(4):558-63.
1997: JJ Bauer; Roger R Connelly; Isabell A Sesterhenn; MC Bettencourt; David G McLeod; sudhir srivastava; Judd W Moul
Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy.
Cancer 1997;79(5):952-62.
1997: Jaya P Gaddipati; David G McLeod; Isabell A Sesterhenn; C J Hussussian; Y A Tong; Pankaj Seth; N C Dracopoli; Judd W Moul; Shiv Srivastava
Mutations of the p16 gene product are rare in prostate cancer.
The Prostate 1997;30(3):188-94.
1996: Robert L Becker; U V Mikel; W R Oliver; Isabell A Sesterhenn
Enumeration of interphase chromosomes. Comparison of visual in situ hybridization and confocal fluorescence in situ hybridization.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1996;18(5):405-9.
1996: JJ Bauer; Isabell A Sesterhenn; Fathollah K Mostofi; David G McLeod; Shiv Srivastava; Judd W Moul
Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer.
The Journal of urology 1996;156(4):1511-6.
1996: M C Bettencourt; JJ Bauer; Isabell A Sesterhenn; Fathollah K Mostofi; David G McLeod; Judd W Moul
Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.
The Journal of urology 1996;156(3):1064-8.
1996: Judd W Moul; M C Bettencourt; Isabell A Sesterhenn; Fathollah K Mostofi; David G McLeod; sudhir srivastava; JJ Bauer
Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.
Surgery 1996;120(2):159-66; discussion 166-7.
1996: Bruce Wenig; Lester Thompson; Sarah Schlesinger Frankel; Allen P Burke; Susan L Abbondanzo; Isabell A Sesterhenn; D K Heffner
Lymphoid changes of the nasopharyngeal and palatine tonsils that are indicative of human immunodeficiency virus infection. A clinicopathologic study of 12 cases.
The American journal of surgical pathology 1996;20(5):572-87.
1995: Judd W Moul; Isabell A Sesterhenn; R R Connelly; T Douglas; sudhir srivastava; Fathollah K Mostofi; David G McLeod
Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
JAMA : the journal of the American Medical Association 1995;274(16):1277-81.
1995: Charles J Davis; J H Barton; Isabell A Sesterhenn; Fathollah K Mostofi
Metanephric adenoma. Clinicopathological study of fifty patients.
The American journal of surgical pathology 1995;19(10):1101-14.
1995: N S Schenkman; Isabell A Sesterhenn; L Washington; Y A Tong; Christopher M Weghorst; Gregory S Buzard; Shiv Srivastava; Judd W Moul
Increased p53 protein does not correlate to p53 gene mutations in microdissected human testicular germ cell tumors.
The Journal of urology 1995;154(2 Pt 1):617-21.
1995: H B Heidenberg; Isabell A Sesterhenn; Jaya P Gaddipati; Christopher M Weghorst; Gregory S Buzard; Judd W Moul; Shiv Srivastava
Alteration of the tumor suppressor gene p53 in a high fraction of hormone refractory prostate cancer.
The Journal of urology 1995;154(2 Pt 1):414-21.
1995: Fathollah K Mostofi; G P Murphy; C Mettlin; Isabell A Sesterhenn; J G Batsakis; S U Khaliq; V Nadimpalli; S Tahan; D B Siders; J Kollin
Pathology review in an early prostate cancer detection program: results from the American Cancer Society-National Prostate Cancer Detection Project.
The Prostate 1995;27(1):7-12.
1995: JJ Bauer; Isabell A Sesterhenn; Raymond A Costabile
Myxoid liposarcoma of the scrotal wall.
The Journal of urology 1995;153(6):1938-9.
1995: Charles J Davis; Fathollah K Mostofi; Isabell A Sesterhenn
Renal medullary carcinoma. The seventh sickle cell nephropathy.
The American journal of surgical pathology 1995;19(1):1-11.
1994: E B Fernandez; Isabell A Sesterhenn; W F McCarthy; Fathollah K Mostofi; Judd W Moul
Proliferating cell nuclear antigen expression to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors.
The Journal of urology 1994;152(4):1133-8.
1994: D J Lewis; Isabell A Sesterhenn; W F McCarthy; Judd W Moul
Immunohistochemical expression of P53 tumor suppressor gene protein in adult germ cell testis tumors: clinical correlation in stage I disease.
The Journal of urology 1994;152(2 Pt 1):418-23.
1994: Jaya P Gaddipati; David G McLeod; H B Heidenberg; Isabell A Sesterhenn; M J Finger; Judd W Moul; Shiv Srivastava
Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.
Cancer research 1994;54(11):2861-4.
1994: Judd W Moul; W F McCarthy; E B Fernandez; Isabell A Sesterhenn
Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer.
Cancer research 1994;54(2):362-4.
1994: D J Lewis; Judd W Moul; S C Williams; Isabell A Sesterhenn; E Colon
Perirenal liposarcoma containing extramedullary hematopoiesis associated with renal cell carcinoma.
Urology 1994;43(1):106-9.
1993: E J Kuhn; R A Kurnot; Isabell A Sesterhenn; E H Chang; Judd W Moul
Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma.
The Journal of urology 1993;150(5 Pt 1):1427-33.
1993: Judd W Moul; J P Foley; C L Hitchcock; W F McCarthy; Isabell A Sesterhenn; Robert L Becker; J L Griffin
Flow cytometric and quantitative histological parameters to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors.
The Journal of urology 1993;150(3):879-83.
1993: Fathollah K Mostofi; Isabell A Sesterhenn; C J Davis
A pathologist's view of prostatic carcinoma.
Cancer 1993;71(3 Suppl):906-32.
1992: Fathollah K Mostofi; C J Davis; Isabell A Sesterhenn
Pathology of carcinoma of the prostate.
Cancer 1992;70(1 Suppl):235-53.
1992: Fathollah K Mostofi; Isabell A Sesterhenn; C J Davis
Prostatic carcinoma: problems in the interpretation of prostatic biopsies.
Human pathology 1992;23(3):223-41.
1992: James L Mohler; Alan W Partin; Jonathan I Epstein; Robert L Becker; U V Mikel; Isabell A Sesterhenn; F K Mostofi; D F Gleason; Y Sharief; Donald S Coffey
Prediction of prognosis in untreated stage A2 prostatic carcinoma.
Cancer 1992;69(2):511-9.
1992: Isabell A Sesterhenn; Fathollah K Mostofi; R R Mattrey; J P Sands; Charles J Davis; W F McCarthy
Preliminary results of three-dimensional reconstruction of previously imaged prostates.
The Prostate. Supplement 1992;4():33-41.
1992: Fathollah K Mostofi; Isabell A Sesterhenn; Charles J Davis
Prostatic intraepithelial neoplasia (PIN): morphological clinical significance.
The Prostate. Supplement 1992;4():71-7.
1992: Isabell A Sesterhenn; R B Weiss; Fathollah K Mostofi; D M Stablein; R G Rowland; G Falkson; S E Rivkind; N J Vogelzang
Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):69-78.
1991: Fathollah K Mostofi; Isabell A Sesterhenn; Charles J Davis
Can pathology predict response role of classic methods and modern techniques.
Progress in clinical and biological research 1991;370():237-48.
1990: Brett Delahunt; Fathollah K Mostofi; Isabell A Sesterhenn; J L Ribas; F A Avallone
Nucleolar organizer regions in seminoma and intratubular malignant germ cells.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1990;3(2):141-5.
1989: Fathollah K Mostofi; Isabell A Sesterhenn; C J Davis
Malignant change in hyperplastic prostate glands. The AFIP experience.
Urology 1989;34(6 Suppl):49-51.
1989: T T Antonovych; S G Sabnis; S M Tuur; Isabell A Sesterhenn; James E Balow
Morphologic differences between polyarteritis and Wegener's granulomatosis using light, electron and immunohistochemical techniques.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1989;2(4):349-59.
1989: J L Ribas; Hernando Mena; KG Braund; Isabell A Sesterhenn; Maria A Toivio-Kinnucan
A histologic and immunocytochemical study of choroid plexus tumors of the dog.
Veterinary pathology 1989;26(1):55-64.
1989: J E Fowler; Isabell A Sesterhenn; Fathollah K Mostofi
Detection of AFP and HCG in metastatic testicular cancer after treatment with chemotherapy or radiation therapy.
Urology 1989;33(1):74-7.
1988: G S Allaire; L Rabin; Kamal G Ishak; Isabell A Sesterhenn
Bile duct adenoma. A study of 152 cases.
The American journal of surgical pathology 1988;12(9):708-15.
1988: Fathollah K Mostofi; Isabell A Sesterhenn; C J Davis
Developments in histopathology of testicular germ cell tumors.
Seminars in urology 1988;6(3):171-88.
1988: Fathollah K Mostofi; Charles J Davis; Isabell A Sesterhenn
Progress in pathology of tumors of the urinary tract.
Progress in clinical and biological research 1988;277():1-20.
1988: Fathollah K Mostofi; Isabell A Sesterhenn; Charles J Davis
Benign tumors of the kidney.
Progress in clinical and biological research 1988;269():329-46.
1987: Fathollah K Mostofi; Isabell A Sesterhenn; C J Davis
Immunopathology of germ cell tumors of the testis.
Seminars in diagnostic pathology 1987;4(4):320-41.
1987: Fathollah K Mostofi; Isabell A Sesterhenn; Charles J Davis
Progress in pathology of carcinoma of prostate.
Progress in clinical and biological research 1987;243A():445-75.
1985: Zachary D Goodman; Kamal G Ishak; J M Langloss; Isabell A Sesterhenn; L Rabin
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
Cancer 1985;55(1):124-35.
1984: Kamal G Ishak; Isabell A Sesterhenn; Zachary D Goodman; L Rabin; F W Stromeyer
Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases.
Human pathology 1984;15(9):839-52.